T/S Ad Slant (What is this?)
The T/S Ad Slant, similar to an advertorial in a magazine or newspaper, is a form of paid advertising. Each T/S Ad Slant is written, edited, and produced by the advertiser with tools like those used by True/Slant contributors. Please contact advertise@trueslant.com for more information.
Sponsor Message

Jun. 7 2010 — 5:10 pm | 68 views | 0 recommendations | 0 comments

2010 BIO International Convention: Fulfilling the Promise to Heal, Fuel and Feed the World

The 2010 BIO International Convention drew biotech industry leaders from around the world to Chicago, Illinois for networking, dealmaking and partnering discussions. More than 15,000 industry leaders from 49 states and 65 countries attended the event. The Convention brought more than $25 million to the local economy and the sector as a whole is continuing to generate high wage jobs for the 21st century economy. Mayor Daley recognized the value of biotech for his city, “We need biotechnology business in Chicago to expand because it provides opportunities for our citizens. BIO – Welcome to our city.”

Indeed, biotechnology has been an engine for growth for the country as a whole.  Al Gore emphasized the economic impact biotechnology has had during his keynote address to Convention attendees. Governor Granholm of Michigan echoed Vice President Gore’s comments and noted the impact for her state, “we have been working to grow Michigan’s life sciences sector as part of our strategy to diversify the state’s economy and create jobs.” Presidents Bill Clinton and George W. Bush, the 42nd and 43rd Presidents of the United States, shared the stage to discuss global issues and biotechnology applications.

Jim Greenwood President and CEO of BIO looks at genetically engineered pigs on the exhibit floor.

In addition to the economic value of biotechnology, the industry is providing health and medical, industrial and environmental, and agricultural improvements to communities all over the world on a daily basis. A new report released at Convention, “Healing, Fueling, Feeding: How Biotechnology is Enriching Your Life,” illustrated some of the positive ways biotechnology is making a difference around the world. For example, biotechnology is responsible for:

  • More than 250 biotechnology healthcare products and vaccines available to patients;
  • More than 50 biorefineries being built across North America to produce biofuels and chemicals from renewable biomass;
  • More than 13.3 million farmers around the world use agricultural biotechnology to increase yields, prevent pest damage and reduce farming’s environmental impact.

U.S. Surgeon General Regina Benjamin delivers keynote address at the Diversity Summit

Several other notable experts and leaders discussed the promise and potential of biotech throughout the four-day event. U.S. Surgeon General, Dr. Regina Benjamin, provided a keynote at the Diversity in Biotechnology Summit which highlighted the “growing racial disconnect between those who seek care and those who provide it,” adding that the imbalance is best offset through improved science education at an early age. CNN Moderator Fareed Zakaria shared his thoughts on the “vast numbers of people and countries [who] can actively participate in the world economy and the growth of the knowledge economy,” at a session highlighting the latest Worldview report.

2010 Biotech Humanitarian Award Honoree Bob Klein

Biotechnology has a tangible humanitarian impact on millions of people every day. This year we awarded our second annual Biotech Humanitarian Award to Bob Klein, a stem cell advocate who has stewarded a new era of stem cell research and discovery in California. Bob Klein’s vision and determination to create alternatives to federal funding for stem cell research helped make the state of California a global leader in disease research.

Officials cut the ribbon at the opening of the exhibit floor

In short, the global event for biotechnology was a huge success. There is more work to be done, more problems to address through biotechnology, and of course – preparing for the 2011 BIO International Convention in Washington, DC. For more information on the 2010 BIO International Convention, please visit  http://convention.bio.org/

Other highlights include:

Apr. 9 2010 — 2:03 pm | 89 views | 0 recommendations | 1 comment

Greenwood leads health care reform discussion on CNBC’s Squawkbox

Late last week, BIO President and CEO Jim Greenwood co-hosted CNBC’s Squawkbox and discussed health care reform, biosimilars and biomedical innovation. In the first segment, Greenwood explains how the biosimilars provision contained in the health care reform law will help patients and allow the biotech industry to continue to provide innovative new therapies. In the second segment, Ron Cohen, President and CEO of Acorda Therapeutics, Inc. and Richard Pops, Chairman, President and CEO of Alkermes, Inc., joined Greenwood for a deeper discussion on biosimilars, biomedical innovation and their companies’ latest breakthroughs.

Apr. 5 2010 — 10:51 am | 9 views | 0 recommendations | 0 comments

 Washington region lures biotech firms through tax breaks, grants | Washington Examiner

Washington region bets big on biotech | Washington Examiner.

Feb. 24 2010 — 2:41 pm | 117 views | 0 recommendations | 2 comments

BIO Opens Nominations for the 2010 George Washington Carver Award for Innovation in Industrial Biotechnology

I am pleased to announce that BIO is opening nominations to the third annual George Washington Carver Award which recognizes significant contributions by an individual to the field of industrial biotechnology, including applications in biological engineering, environmental science, biorefining and biobased products.  Nominees must be living individuals in the private sector, government or academia who have demonstrated significant and innovative accomplishments employing industrial biotechnology to advance a biobased economy and industrial sustainability. Nominations can be made online at http://bio.org/worldcongress/program/carver.asp until April 12, 2010.

The 2010 Award will be presented at the 2010 World Congress on Industrial Biotechnology and Bioprocessing, June 27-30, 2009 in Washington, D.C. An accompanying George Washington Carver scholarship to Iowa State University will be awarded in the name of the recipient.

This Award honors the original vision of George Washington Carver who, over a century ago, achieved world renown by using agriculture and science to produce everyday products, changing the nature of farm economics and ushering in the era of modern industrial biotechnology. His efforts inspire contemporary biotechnology companies that are developing new methods to use renewable agricultural resources to manufacture fuels, plastics, chemicals, pharmaceuticals and food ingredients, just as Carver did during the first half of the 20th century.

As Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section, noted, “science has developed in ways that Carver may never have imagined, but the work remains true to his goal – a sustainable agricultural economy that includes production of useful everyday products.”

The 2009 George Washington Carver Award honored DuPont Chairman of the Board Charles O. Holliday, Jr., who was recognized for his commitment to industrial biotechnology as a tool for sustainable business growth. During Holliday’s tenure as CEO, DuPont invested in biology-based businesses and infused them with its chemistry know-how. For instance, DuPont partnered with sugar processor Tate & Lyle to manufacture 1,3 propanediol, a polyester ingredient made by fermenting sugar. That venture led the company to think about applying its fermentation expertise to making renewable fuels and chemicals in a biorefinery.

The 2008 Honoree was Dr. Patrick Gruber, CEO, Gevo, Inc., who was recognized for his accomplishments in creating and commercializing a new plastic made from annually renewable resources.

The annual World Congress on Industrial Biotechnology and Bioprocessing is the original and only conference dedicated solely to industrial biotechnology and the most recent advancements in the field. To learn more about the conference please visit www.bio.org/worldcongress.

And remember to nominate an innovator in industrial biotechnology for this recognition.

Feb. 16 2010 — 12:16 pm | 137 views | 0 recommendations | 2 comments

After the Storm: The Sun is Shining on Biotech

As the Northeast digs out from tremendous snow storms, I watched the biotech industry demonstrate its strength and vitality, its ability to fend off – and persevere through – the economic storm that recently took hold of our country.  The robust activity at the 12th Annual BIO CEO & Investor Conference, held February 8 and 9 in New York City, is another indication of the strong economic potential of the biotech sector and the tremendous promise of the science to transform how we live.  (The BIO CEO & Investor Conference is the largest investor conference focused on publicly traded biotech companies.)

We’re proud to say that the number of one-on-one meetings at the conference was up over 20 percent from the 2009 conference.  Many of the panels were well-received – and well-attended – featuring clinical investigators, key opinion leaders and companies with upcoming regulatory and clinical catalysts.  Gilead, Human Genome Sciences, Dendreon and Acorda were just some of the high quality companies that presented at the conference.

We expect to see similar activity and energy at the 2010 BIO International Convention taking place May 3-6 in Chicago, which will feature the BIO Business Forum.  During the 2009 forum, a record-setting 14,202 30-minute partnering meetings, involving more than 1,700 companies took place.  BIO expects the 2010 forum to continue to foster license, investments and company interactions.

Without a doubt, things still need to improve for biotech.  Overall investment is down, and times are tough for many companies.  Despite those obstacles, our scientists are continuing to push forward.  A number of companies with strong clinical results are helping to drive and bolster investor confidence.  We are hopeful that as the markets improve, investor confidence will continue to rise.  And soon patients and consumers will realize the benefits of the scientific breakthroughs coming our way.


Biotechnology Central
Biotechnology Central is the place to learn about the breakthroughs big and small that are happening in the world of biotech. Biotechnology has the power to heal, fuel and feed the world by building upon our knowledge of biological systems, DNA and the human genome.

This T/S AdSlant is written, edited, and produced by the Biotechnology Industry Organization (BIO), an organization that represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.

* BIO.org


* BiotechNow


* Biofuels and Climate Change


* Blogging BIOtech


* Farmer Gene


* IAmBiotech


* What Can Biotech Do For You?


* Eleventh Hour Facts


See our profile »

Our Contributors

Jim GreenwoodJim Greenwood
Jeff JosephJeff Joseph
Steve SherwinSteve Sherwin
Followers: 3
Contributor Since: December 2009

Our Activity Feed